Cargando…
High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is still a lethal malignancy. Long noncoding RNAs (lncRNAs) have been shown to play a critical role in cancer development and progression. Here we identified overexpression of the lncRNA AFAP1-AS1 in PDAC patients and evaluated its prognostic and f...
Autores principales: | Ye, Yibiao, Chen, Jie, Zhou, Yu, Fu, Zhiqiang, Zhou, Quanbo, Wang, YingXue, Gao, Wenchao, Zheng, ShangYou, Zhao, Xiaohui, Chen, Tao, Chen, Rufu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458022/ https://www.ncbi.nlm.nih.gov/pubmed/25925763 http://dx.doi.org/10.1186/s12967-015-0490-4 |
Ejemplares similares
-
FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma
por: Ye, Huilin, et al.
Publicado: (2018) -
Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma
por: Ye, Huilin, et al.
Publicado: (2018) -
Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers
por: Wang, Yingxue, et al.
Publicado: (2015) -
circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway
por: Zheng, Shangyou, et al.
Publicado: (2022) -
A novel gene signature for prognosis prediction and chemotherapy response in patients with pancreatic cancer
por: Lin, Hongcao, et al.
Publicado: (2021)